Pfetin predicts outcome for patients with gastrointestinal stromal tumors
This article has no abstract so we have provided the first paragraph of the full text.
The molecular background of gastrointestinal stromal tumors (GISTs) has been investigated through genome and transcriptome studies, but the proteomic profile of these tumors has not yet been established. Suehara et al. conducted a quantitative expression study of intact proteins in GIST samples to investigate this profile and determined that decreased expression of pfetin predicts poor outcome in patients with these tumors.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.